Therapeutic potential of oleanolic acid in liver diseases
Naunyn-Schmiedeberg's Archives of Pharmacology · 2024-07 · 397 (7) · 4537-4554
DOI: 10.1007/s00210-024-02959-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 31.01.2024. Verfasst von Yongxin Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery II, General Surgery Center, The First Hospital of Jilin University, Changchun, 130021, China. Hauptthemen laut MEDLINE: Oleanolic Acid, Liver Diseases. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 154 Literaturangaben. Gefördert von: Beijing Medical Award Foundation.
Abstract (Originalsprache)
Liver-associated diseases affect millions of individuals worldwide. In developed countries, the incidence of viral hepatitis is reducing due to advancements in disease prevention, diagnosis, and treatment. However, with improvements in living standards, the prevalence of metabolic liver diseases, such as non-alcoholic fatty liver disease and alcohol-related liver disease, is expected to increase; notably, this rise in the prevalence of metabolic liver disease can lead to the development of more severe liver diseases, including liver failure, cirrhosis, and liver cancer. The growing demand for natural alternative therapies for chronic diseases has highlighted the importance of studying the pharmacology of bioactive compounds in plants. One such compound is oleanolic acid (OA), a pentacyclic triterpenoid known for its antioxidant, anti-inflammatory, anti-ulcer, antibacterial, antiviral, antihypertensive, anti-obesity, anticancer, anti-diabetic, cardioprotective, hepatoprotective, and anti-neurodegenerative properties. Recent studies have demonstrated that OA treatment can reduce the risk of pathological liver damage, ultimately alleviating liver dysregulation and restoring overall liver function. This review aims to explore the latest research on the biological effects of OA and its derivatives. Notably, it explores the mechanisms of action of these compounds in both in vitro and in vivo research models and, ultimately, highlights OA as a promising candidate for alternative therapies in the treatment and management of chronic liver disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery II, General Surgery Center, The First Hospital of Jilin University, Changchun, 130021, China.
- Department of Hepatobiliary and Pancreatic Surgery II, General Surgery Center, The First Hospital of Jilin University, Changchun, 130021, China. liuk@jlu.edu.cn.
Förderung
- Beijing Medical Award Foundation
Zitieren
APA
Wang, Y., & Liu, K. (2024). Therapeutic potential of oleanolic acid in liver diseases. Naunyn-Schmiedeberg's Archives of Pharmacology, 397(7), 4537-4554. https://doi.org/10.1007/s00210-024-02959-2
Vancouver
Wang Y, Liu K. Therapeutic potential of oleanolic acid in liver diseases. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024;397(7):4537-4554. doi:10.1007/s00210-024-02959-2
BibTeX
@article{Wang2024,
author = {Wang, Yongxin and Liu, Kai},
title = {Therapeutic potential of oleanolic acid in liver diseases},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2024},
volume = {397},
number = {7},
pages = {4537--4554},
doi = {10.1007/s00210-024-02959-2}
}
EUVIMED